Mu Therapeutics Inc
Mu Therapeutics Inc, based in Austin, TX, specializes in the development of targeted radiotherapeutics aimed at treating rare and challenging cancers in both adults and children. Their innovative approach utilizes Rhenium radioisotopes encapsulated in nanoliposomes and biodegradable microspheres to deliver precise radiation therapy while minimizing damage to healthy tissues.
The company's lead products include REYOBIQ, a radiolabeled nanoliposome therapy for brain and CNS cancers, and 188RNL-BAM, a next-generation radioembolization therapy designed for various solid organ cancers. By leveraging cutting-edge drug formulations and treatment technologies, Mu Therapeutics is dedicated to improving patient outcomes and extending quality of life through innovative cancer therapies.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

